EVFCX
Price
$9.82
Change
-$0.02 (-0.20%)
Updated
Nov 14 closing price
PACAX
Price
$10.98
Change
-$0.02 (-0.18%)
Updated
Nov 14 closing price
Ad is loading...

EVFCX vs PACAX

Header iconEVFCX vs PACAX Comparison
Open Charts EVFCX vs PACAXBanner chart's image
E-Valuator Cnsv (15%-30%) RMS R4
Price$9.82
Change-$0.02 (-0.20%)
VolumeN/A
CapitalizationN/A
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.98
Change-$0.02 (-0.18%)
VolumeN/A
CapitalizationN/A
EVFCX vs PACAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EVFCX vs. PACAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVFCX is a Sell and PACAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PACAX has more cash in the bank: 576M vs. EVFCX (49.1M). EVFCX pays higher dividends than PACAX: EVFCX (3.59) vs PACAX (2.18). EVFCX was incepted earlier than PACAX: EVFCX (8 years) vs PACAX (31 years). PACAX is a more actively managed with annual turnover of: 456.00 vs. EVFCX (148.00). PACAX has a lower initial minimum investment than EVFCX: PACAX (0) vs EVFCX (10000). PACAX annual gain was more profitable for investors over the last year : 16.76 vs. EVFCX (10.78). PACAX return over 5 years is better than : 11.40 vs. EVFCX (4.18).
EVFCXPACAXEVFCX / PACAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years31 years-
Gain YTD6.02110.12359%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets49.1M576M9%
Annual Yield % from dividends3.592.18164%
Returns for 1 year10.7816.7664%
Returns for 3 years-7.66-2.74279%
Returns for 5 years4.1811.4037%
Returns for 10 years18.0015.39117%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGCX16.980.11
+0.65%
Grandeur Peak Global Contrarian Instl
FIUSX38.16N/A
N/A
Delaware Opportunity A
JHLVX62.38N/A
N/A
JHancock Fundamental Large Cap Core C
NSFEX11.43-0.04
-0.35%
Natixis Target Retirement 2025 N
ETNHX34.80-0.82
-2.30%
Eventide Healthcare & Life Sciences N